A clinical trial participant from #GAPNet site, JEM Research, talks with her husband about their experience in the Aducanumab trial, which is pending approval by the US Food and Drug Administration by March 2021. There are currently more than five million Americans living with Alzheimer’s disease… and despite ongoing research, there has been no new […]
Aducanumab for Alzheimer’s: One Drug, Two Results
